ANI Pharmaceuticals, Inc. (ANIP) vs Phibro Animal Health Corporation (PAHC)
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
ANI Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. and Phibro Animal Health Corporation are of similar size ($1.7B and $1.5B). ANI Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 15.8×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against 17.1%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs 6.57%) and the lower return on invested capital (11.3% vs 11.7%). Across the 22 metrics below, ANI Pharmaceuticals, Inc. leads on 16 and Phibro Animal Health Corporation on 6.
Valuation
Profitability
| Metric | ANIP | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 33.76% | 53.94% |
| Operating margin | 15.37% | 12.81% | 0.00% |
| Net margin | 11.04% | 6.57% | 0.00% |
| Free cash flow margin | 17.12% | 0.65% | 0.00% |
| Return on equity | 20.88% | 29.72% | (0.40%) |
| Return on assets | 7.61% | 6.97% | (3.32%) |
| Return on invested capital | 11.30% | 11.72% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack